Eagle Genomics Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 14

Eagle Genomics General Information

Description

Developer of smart data management platform designed to conduct data-intensive research in life sciences. The company's platform provides an easy to use intuitive approach for curating, integrating, sharing, analyzing and valuing scientific data for clinical and molecular studies in life sciences and fields where similar challenges have been addressed, enabling biotechnology companies to deliver game-changing products and technologies into their respective markets.

Contact Information

Website
www.eaglegenomics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Primary Office
  • 90 York Way
  • London N1 9AG
  • England, United Kingdom

Eagle Genomics Timeline

2017201820192020
Financing RoundFinancing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Eagle Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Accelerator/Incubator 12-Nov-2019 00.000 Completed Generating Revenue
10. Accelerator/Incubator 30-Jul-2019 00.000 Completed Generating Revenue
9. Later Stage VC 04-Feb-2019 00.00 00.000 000 Completed Generating Revenue
8. Later Stage VC 20-Jun-2018 00.000 00.000 00.000 Completed Generating Revenue
7. Accelerator/Incubator 09-Mar-2018 00.000 Completed Generating Revenue
6. Grant 09-Feb-2018 00.000 00.000 Completed Generating Revenue
5. Grant 01-Aug-2017 00000 00.000 Completed Generating Revenue
4. Later Stage VC 25-Nov-2016 00.000 00.000 000 Completed Generating Revenue
3. Later Stage VC 24-Aug-2015 $624K $2.23M 00.000 Completed Generating Revenue
2. Early Stage VC 22-Nov-2013 $1.61M $1.61M 00.000 Completed Generating Revenue
To view Eagle Genomics’s complete valuation and funding history, request access »

Eagle Genomics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary 00 00.000000 0000.0 0000.0 00 0000.0 0.000
Series A 000 00.000000 000.00 000.00 00 000.00 0.000
Series A 00,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 0,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 00,000 00.000000 000 000 00 000 00.000
Ordinary 8,689 $0.010000 $46.04 $46.04 1x $46.04 9.05%
Ordinary 12,000 $0.010000 $83.33 $83.33 1x $83.33 12.5%
To view Eagle Genomics’s complete cap table history, request access »

Eagle Genomics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of smart data management platform designed to conduct data-intensive research in life sciences. The company's
Other Healthcare Technology Systems
London, United Kingdom
00.000
000000000000 00.000

000000 0

dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut ali
0000000000000
Saint Sulpice, Switzerland
000 As of 0000
00000
00000000000 00000

0000000

elit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, su
0000000000000
San Francisco, CA
00 As of 0000
000.00
0&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Eagle Genomics Competitors (33)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sophia Genetics Venture Capital-Backed Saint Sulpice, Switzerland 000 00000 00000000000 00000
0000000 0 Formerly VC-backed San Francisco, CA 00 000.00 0&0 000.00
000000 00000000 Venture Capital-Backed Seattle, WA 0 00.000 00000000000 00.000
00000000 Venture Capital-Backed Houston, TX 00 00.000 0000000000 0 00.000
00000000 Venture Capital-Backed Mountain View, CA 000 00000 00000000000 00000
You’re viewing 5 of 33 competitors. Get the full list »

Eagle Genomics Executive Team (12)

Name Title Board Seat Contact Info
Anthony Finbow Chief Executive Officer
Gavin Horn Chief Financial Officer
Radouane Oudrhiri Chief Data Scientist & Chief Technology Officer
You’re viewing 3 of 12 executive team members. Get the full list »

Eagle Genomics Board Members (12)

Name Representing Role Since
Clifford Meltzer Self Non-Executive Chairman 000 0000
Delphine Gény-Stephann Eagle Genomics Board Member 000 0000
Robert Genieser ETF Partners Board Member 000 0000
Simon Thorpe Self Board Member 000 0000
Tomer Strikovsky Self Board Observer 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Eagle Genomics Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
EIT Food Accelerator/Incubator Minority 000 0000 000000 0
JLABS Accelerator/Incubator Minority 000 0000 000000 0
ETF Partners Venture Capital Minority 000 0000 000000 0
Delta2020 Venture Capital Minority 000 0000 000000 0
Microsoft ScaleUp Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial